Table 3.
Characteristics of current TZD users, based on one random prescription per patient.
| GPRD | PHARMO | Danish registries | |
|---|---|---|---|
| Random TZD prescriptions | Random TZD prescriptions | Random TZD prescriptions | |
| n = 38,438 | n = 15,118 | n = 7,603 | |
| Sex female | 42.9% | 52.1% | 42.7% |
| Mean age at prescription date | 64.3 | 63.2 | 61.6 |
| Mean number of TZD prescriptions before | 14.2 | 6.3 | 7.6 |
| Mean duration of follow-up after index date, yrs | 4.2 | 3.8 | 5.5 |
| CURRENT USE OF | |||
| Biguanide | 77.5% | 66.2% | 85.2% |
| Sulfonylureum | 53.7% | 54.4% | 47.2% |
| Insulin | 5.2% | 10.2% | 9.4% |
| Other | 4.7% | 1.8% | 6.4% |